{"id":"https://openalex.org/W2476683176","doi":"https://doi.org/10.1201/b16633-21","title":"Current and Potential Applications of Pharmacogenetics and Pharmacogenomics","display_name":"Current and Potential Applications of Pharmacogenetics and Pharmacogenomics","publication_year":2014,"publication_date":"2014-02-19","ids":{"openalex":"https://openalex.org/W2476683176","doi":"https://doi.org/10.1201/b16633-21","mag":"2476683176"},"language":"en","primary_location":{"id":"doi:10.1201/b16633-21","doi":"https://doi.org/10.1201/b16633-21","is_oa":false,"landing_page_url":"https://doi.org/10.1201/b16633-21","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547"],"host_organization_lineage_names":["CRC Press","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Moderate to Severe Psoriasis","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W3125452449","display_name":"Moderate to Severe Psoriasis"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082548409","display_name":"Rishu Gupta","orcid":"https://orcid.org/0000-0002-5642-9493","observed_orcids":["https://orcid.org/0000-0002-5642-9493"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rishu Gupta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078581958","display_name":"Wilson J. Liao","orcid":"https://orcid.org/0000-0001-7883-6439","observed_orcids":["https://orcid.org/0000-0001-7883-6439"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wilson Liao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102727788","display_name":"John Y. M. Koo","orcid":"https://orcid.org/0009-0004-1005-5221","observed_orcids":["https://orcid.org/0009-0004-1005-5221"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Y. M. Koo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5069063369","display_name":"Jashin J. Wu","orcid":"https://orcid.org/0000-0002-1722-1892","observed_orcids":["https://orcid.org/0000-0002-1722-1892"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jashin J. Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.16042781,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"349","last_page":"360"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8374000191688538,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8374000191688538,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.11720000207424164,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.009399999864399433,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.9190000295639038},{"id":"https://openalex.org/keywords/pharmacogenomics","display_name":"pharmacogenomics","score":1.0},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/personalized-treatment","display_name":"personalized treatment","score":0.6299999952316284},{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":0.8510000109672546},{"id":"https://openalex.org/keywords/treatment-response-variability","display_name":"treatment response variability","score":0.46799999475479126}],"concepts":[{"id":"https://openalex.org/C170734499","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenomics","level":2,"score":0.8965846300125122},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.7923060655593872},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3416106104850769},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28614920377731323},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.19374454021453857},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15844321250915527},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.07812932133674622},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.03927290439605713}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1201/b16633-21","doi":"https://doi.org/10.1201/b16633-21","is_oa":false,"landing_page_url":"https://doi.org/10.1201/b16633-21","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547"],"host_organization_lineage_names":["CRC Press","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Moderate to Severe Psoriasis","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2021018799"],"related_works":["https://openalex.org/W2488129461","https://openalex.org/W7023736933","https://openalex.org/W2114708721","https://openalex.org/W3032612984","https://openalex.org/W1983554452","https://openalex.org/W1992810398","https://openalex.org/W2728660300","https://openalex.org/W2058830337","https://openalex.org/W2617679056","https://openalex.org/W2153607442"],"abstract_inverted_index":{"Psoriasis":[0],"is":[1,57,65,71],"a":[2,41,74,110,122],"common,":[3],"chronic":[4],"skin":[5],"disease":[6,14],"affecting":[7],"approximately":[8],"2%\u20133%":[9],"of":[10,21,30,36,55,76,119,132],"American":[11],"adults.":[12],"The":[13,53,100],"not":[15],"only":[16],"affects":[17],"the":[18,48,86,104,117,129],"physical":[19],"health":[20,50],"patients":[22,46],"but":[23],"can":[24],"also":[25,127],"lead":[26],"to":[27,84,92,102],"substantial":[28],"impairment":[29],"psychosocial":[31],"well-being":[32],"and":[33,47,61,134],"overall":[34,49],"quality":[35],"life.":[37],"Furthermore,":[38,121],"psoriasis":[39,56,94],"represents":[40],"significant":[42],"financial":[43],"cost":[44],"for":[45,90,109],"care":[51],"system.":[52],"development":[54],"multifactorial,":[58],"including":[59,79],"genetic":[60,112],"environment":[62],"factors.":[63],"Methotrexate":[64],"an":[66],"effective":[67,105],"immunosuppressive":[68],"agent":[69],"that":[70],"used":[72],"in":[73,136],"number":[75],"dermatologic":[77],"conditions,":[78],"psoriasis.":[80],"Many":[81],"considered":[82],"methotrexate":[83],"be":[85],"gold":[87],"standard":[88],"treatment":[89,138],"moderate":[91],"severe":[93],"as":[95,97],"well":[96],"psoriatic":[98],"arthritis.":[99],"ability":[101],"develop":[103],"therapeutic":[106,124],"agents":[107],"individualized":[108],"specific":[111],"composition":[113],"would":[114],"truly":[115],"revolutionize":[116],"practice":[118],"medicine.":[120],"targeted":[123],"approach":[125],"will":[126],"decrease":[128],"inherent":[130],"expenditure":[131],"time":[133],"finances":[135],"failed":[137],"regimens.":[139]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-08-23T00:00:00"}